IL-5-induced airway eosinophilia - The key to asthma?

Immunological Reviews

Volumn 179, Issue , 2001, Pages 182-191

  Hamelmann, Eckard ^a,b   Gelfand, Erwin W ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6;

AIRWAY OBSTRUCTION; ASTHMA; ATOPY; BRONCHUS MUCOSA; CELL INFILTRATION; DISEASE PREDISPOSITION; EOSINOPHIL; EOSINOPHILIA; HELPER CELL; LYMPHOCYTE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASTHMA; BRONCHIAL DISEASES; BRONCHIAL HYPERREACTIVITY; EOSINOPHILIA; GUINEA PIGS; HAPLORHINI; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION; INTERLEUKIN-4; INTERLEUKIN-5; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, NUDE; MODELS, ANIMAL; MODELS, IMMUNOLOGICAL; MUCOUS MEMBRANE; TH2 CELLS;

EID: 0035105112     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.790118.x     Document Type: Review

References (110)

1. Eosinophilic inflammation in asthma
2. The eosinophil and bronchial asthma: Current understanding
3. T cells and eosinophils in the pathogenesis of asthma
4. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status
5. Predominant TH2-1ike bronchoalveolar T-lymphocyte population in atopic asthma
6. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia
7. T-lymphocytes, allergy and asthma
8. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
9. Eosinophils and asthma
10. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls
11. Recombinant human interleukin 5 is a selective activator of human eosinophil function
12. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
13. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor
14. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
15. Cellular events in the bronchi in mild asthma and after bronchial provocation
16. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma
17. Blood eosinophils and eosinophil-derived proteins in allergic asthma
18. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
19. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model
20. Sorting out the cytokines of asthma
21. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
22. 2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
23. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity
24. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
25. +) T cells and eosinophils in allergy and asthma
26. The effects of corticosteroids on cytokine generation and expression of activation antigens by monocytes in bronchial asthma
27. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
28. + T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization
29. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness
30. Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airways function in a murine model of allergen sensitization
31. Nebulized IFN-γ inhibits the development of secondary allergic responses in mice
32. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea
33. + T cell recruitment into tissue
34. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice
35. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia
36. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
37. Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness
38. IL-4 directs the development of TH2-like helper/effectors
39. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1
40. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
41. IL-4 induces coexpression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide
42. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures
43. New concepts about the mast cell
44. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice
45. Attenuation of allergic airway inflammation in IL-4 deficient mice
46. IL-5 but not IgE reconstitutes airway inflammation and hyperresponsiveness in IL-4 deficient mice
47. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
48. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
49. A novel T-cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
50. Immunological basis of antigen-induced airway hyperresponsiveness
51. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice
52. Interleukin-13: Central mediator of allergic asthma
53. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production
54. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5
55. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
56. Eotaxin: A potent eosinophii chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation
57. IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy
58. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
59. The receptor with high affinity for immunoglobulin E
60. The high-affinity receptor for immunoglobulin E
61. Association of asthma with serum IgE levels and skin-test reactivity to allergens
62. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
63. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific IgE and IgG1 in mice
64. Differential requirements for the induction of airway inflammation and airway hyperresponsiveness in IgE-receptor-deficient mice
65. CD23-deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin
66. Modulation of antigen-induced B- and T-cell responses by antigen-specific IgE antibodies
67. A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
68. Active anaphylaxis in IgE-deficient mice
69. Allergic airway sensitization induces T-cell activation but not airway hyperresponsiveness in B-cell-deficient mice
70. Successful T-cell priming in B-cell-deficient mice
71. CD8 T cell memory in B-cell-deficient mice
72. Long-lasting CD8 T cell memory in the absence of CD4 T cells and B cells
73. + T cell activation and tolerance induction in B cell knockout mice
74. B cells are not essential for peripheral T-cell tolerance
75. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
76. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness
77. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
78. Modulation of eosinophil chemotaxis by interleukin-5
79. RANTES- and interleukin-8-induced responses in normal human eosinophils: Effects of priming with interleukin-5
80. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects
81. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma
82. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner
83. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production
84. Eosinophilia in transgenic mice expressing interleukin 5
85. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma
86. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy
87. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5
88. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics
89. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions
90. Cationic proteins alter smooth muscle function by an epithelium-dependent mechanism
91. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor
92. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates
93. Anti-interleukin 5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
94. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
95. Anti interleukin-5 but not anti-IgE prevents development of airway eosinophilia and airway hyperresponsiveness in sensitized mice
96. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes
97. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung
98. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: A therapeutic approach
99. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
100. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
101. Effects of an antibody to interleukin-5 in a monkey model of asthma
102. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses
103. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
104. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness
105. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection
106. Blockade of CD49d (α4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
107. The importance of leukotrienes in airway inflammation in a mouse model of asthma
108. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection